DDReg pharma

DELIVER BETTER DATA TO ENSURE FASTER APPROVAL
DDReg Pharma
Talk To Us

Pharmacovigilance

Kenya’s Systematic Approach to Pharmacovigilance

Blogs, Pharmacovigilance /

Pharmacovigilance (PV) and drug safety surveillance activities rely on a robust PV system. This is important to effectively identify, evaluate, and address any adverse events (AEs) that are associated with medicinal products. Indeed, a proficient PV system facilitates data gathering that is critical for making informed decisions across various health systems. Regulatory agencies are reliant […]

Kenya’s Systematic Approach to Pharmacovigilance Read More »

ISoP: The Need for Patient Engagement in Pharmacovigilance

Blogs, Pharmacovigilance /

Pharmacovigilance is paramount for the well-being of patients exposed to pharmaceutical products. To ensure the effectiveness of pharmacovigilance systems professionals from various scientific disciplines contribute in diverse manner. Several organizations collaborate to ensure best global pharmacovigilance practices for patient safety. Among these key organizations is the International Society of Pharmacovigilance (ISoP) that is dedicated to patient

ISoP: The Need for Patient Engagement in Pharmacovigilance Read More »

Ensuring Safe Use of Medical Devices in Healthcare Facilities

Blogs, Medical Device, Pharmacovigilance /

The safe and effective use of medical devices in healthcare facilities is not merely a matter of convenience; it is a moral obligation. The welfare of patients and the quality of healthcare services depend on the responsible use of these devices. Accidents involving medical devices can have dire consequences for patients. These accidents may result

Ensuring Safe Use of Medical Devices in Healthcare Facilities Read More »

CDER: Creating efficiencies in pharmaceutical development and manufacturing

Blogs, Pharmacovigilance /

The Center for Drug Evaluation and Research (CDER) of the US FDA outlined a program in February 2019 in which various stakeholders of the industry could propose pharmaceutical quality standards for recognition by the CDER. This would provide the industry with additional resources for the development and manufacturing of pharmaceuticals. In July 2023, the CDER

CDER: Creating efficiencies in pharmaceutical development and manufacturing Read More »

The Impact of Artificial Intelligence in the Lifecycle of Medicines

Blogs, Pharmacovigilance, Regulatory /

The rapid digitalization of the biomedical and clinical research sectors has ushered in a new era of advancements, with artificial intelligence (AI) taking centre stage as a transformative solution. In particular, AI is revolutionizing drug discovery processes by harnessing the vast amount of data generated during molecule screening phases and preclinical studies. As a result,

The Impact of Artificial Intelligence in the Lifecycle of Medicines Read More »

The Future of Certificate of Suitability

Blogs, Pharmacovigilance, Regulatory /

The Certificate of Suitability (CEP) to the monographs of the European Pharmacopoeia (Ph. Eur.) plays a crucial role in verifying the quality standards of active pharmaceutical ingredients (APIs). Issued by the European Directorate for the Quality of Medicines (EDQM), the CEP serves as evidence that an API complies with the rigorous quality requirements outlined in

The Future of Certificate of Suitability Read More »

US FDA: Resolving Disputes for Over-the-Counter Monograph Drugs

Blogs, Pharmacovigilance, Regulatory /

Over-The-Counter (OTC) monographs define the safety, effectiveness, and labelling of the active ingredients in OTCs. The US FDA released a guidance document that provides suggestions for industry and review staff on resolving scientific and medical disputes related to OTC monograph drugs. It describes the Center for Drug Evaluation and Research (CDER) formal dispute resolution (FDR)

US FDA: Resolving Disputes for Over-the-Counter Monograph Drugs Read More »

US FDA: Safety Reporting Requirements for Combination Products

Blogs, Pharmacovigilance, Regulatory /

In this new era, where different therapeutic realms converge, the emergence of combination products has revolutionized the healthcare landscape by providing more innovative treatment options to treat the unmet medical needs of patients. However, with great power comes great responsibility. Continuously monitoring these products and ensuring they are safe to use is paramount in order

US FDA: Safety Reporting Requirements for Combination Products Read More »

Challenges in Complex Generic Drug Development

Blogs, Pharmacovigilance, Regulatory /

Complex drugs add more value to patients compared to simple generics as they are capable of addressing unmet needs of patients for particular conditions. However, biopharmaceutical companies encounter distinctive hurdles when it comes to the advancement of complex generic drugs. These medications, known for their intricate characteristics or the requirement of additional clinical trials, necessitate

Challenges in Complex Generic Drug Development Read More »